228 related articles for article (PubMed ID: 15201981)
1. Response of T- and B-lymphocytes in the spleen of mammary tumor-bearing rats to treatment with tamoxifen and soluble tumor-associated antigens.
Ben-Hur H; Kossoy G; Sanko H; Geva D; Shumlin N; Zusman I; Elhayany A
Oncol Rep; 2004 Jul; 12(1):181-5. PubMed ID: 15201981
[TBL] [Abstract][Full Text] [Related]
2. Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin.
Ben-Hur H; Kossoy G; Mehrdad H; Elhayany A; Zusman I
Oncol Rep; 2004 Dec; 12(6):1329-33. PubMed ID: 15547759
[TBL] [Abstract][Full Text] [Related]
3. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
Ben-Hur H; Kossoy G; Zandbank J; Zusman I
Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclophosphamide and soluble tumor-associated antigens on lymphoid infiltration, proliferative activity and rate of apoptosis in chemically-induced rat mammary tumors.
Ben-Hur H; Kossoy G; Tendler Y; Kossoy N; Zusman I
In Vivo; 2002; 16(5):287-92. PubMed ID: 12494865
[TBL] [Abstract][Full Text] [Related]
5. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
Ben-Hur H; Kossoy G; Zusman I
Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
[TBL] [Abstract][Full Text] [Related]
6. Cytological aspects of rat mammary cancer therapy with soluble tumor-associated antigens and anticancer drugs.
Zusman I
Med Sci Monit; 2005 May; 11(5):RA173-181. PubMed ID: 15874908
[TBL] [Abstract][Full Text] [Related]
7. Human soluble tumor-associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil and stimulate the functional activity of immune organs: Experimental and morphological studies.
Kossoy G; Ben-Hur H; Avinoach I; Alhayany A; Shneider DF; Zusman I
Int J Mol Med; 2003 Nov; 12(5):797-801. PubMed ID: 14533012
[TBL] [Abstract][Full Text] [Related]
8. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: the bone marrow and thymus.
Ben-Hur H; Kossoy G; Kossoy N; Zusman I
Int J Mol Med; 2002 Oct; 10(4):517-21. PubMed ID: 12239604
[TBL] [Abstract][Full Text] [Related]
9. Human soluble p66 and p51 tumor-associated antigens promote the suppression of rat mammary tumors in comparison to commercial human albumin.
Kossoy G; Avinoach I; Zusman I; Scheider DP; Ben-Hur H; Elhayany A
Oncol Rep; 2004 Feb; 11(2):487-91. PubMed ID: 14719088
[TBL] [Abstract][Full Text] [Related]
10. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular mass tumor-associated antigens: the spleen and lymph nodes.
Ben-Hur H; Kossoy G; Schneider DF; Zandbank J; Zusman I
Int J Mol Med; 2002 Mar; 9(3):311-6. PubMed ID: 11836638
[TBL] [Abstract][Full Text] [Related]
11. Rat soluble tumor-associated antigens inhibit chemically-induced mammary tumorigenesis in syngeneic rats.
Kossoy G; Ben-Hur H; Elhayany A; Schneider DF; Zusman I
Oncol Rep; 2005 Apr; 13(4):585-8. PubMed ID: 15756427
[TBL] [Abstract][Full Text] [Related]
12. T cell kinetics and apoptosis in immune organs and mammary tumors of rats treated with cyclophosphamide and soluble tumor-associated antigens.
Zusman I; Kossoy G; Ben-Hur H
In Vivo; 2002; 16(6):567-76. PubMed ID: 12494902
[TBL] [Abstract][Full Text] [Related]
13. Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies.
Ben-Hur H; Gurevich P; Zion H; Berman V; Tendler Y; Sandler B; Zinder O; Zusman I
Anticancer Res; 1998; 18(1A):273-81. PubMed ID: 9568090
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen and soluble tumor-associated antigens on ovarian structure in mammary tumor-bearing rats.
Kossoy G; Ben-Hur H; Elhayany A; Schneider DF; Kossoy N; Zusman I
Oncol Rep; 2005 Nov; 14(5):1317-21. PubMed ID: 16211303
[TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
[TBL] [Abstract][Full Text] [Related]
16. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I
Anticancer Res; 1998; 18(6A):4237-41. PubMed ID: 9891473
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor growth by L-deprenyl involves neural-immune interactions in rats with spontaneously developing mammary tumors.
Thyagarajan S; Madden KS; Stevens SY; Felten DL
Anticancer Res; 1999; 19(6B):5023-8. PubMed ID: 10697505
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
Kosaka A; Yamashita A
Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
[TBL] [Abstract][Full Text] [Related]
19. Response of the spleen of Balb/c and p53-transgenic mice to low doses of carcinogen and to polyclonal antibodies generated against the soluble 53 kDa protein.
Tendler Y; Ben-Hur H; Gurevich P; Sandler B; Berman V; Zinder O; Zusman I
Anticancer Res; 2000; 20(1A):385-90. PubMed ID: 10769684
[TBL] [Abstract][Full Text] [Related]
20. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
